There is no single federal standard for who can inject Botox or dermal fillers in the United States. The rules are set state by state, creating a patchwork of licensing laws, supervision requirements, and scope-of-practice boundaries that vary depending on where the patient is treated. A nurse practitioner in Arizona operates under different rules than one in New York. An RN in Texas works under different supervision requirements than an RN in California. Estheticians cannot legally inject anywhere — but some do.
This matters because injector qualification is the single strongest predictor of safety. The FDA's October 2025 safety communication on RF microneedling devices, the CDC's continued alerts on counterfeit Botox, and the rise of med-spa adverse events all trace back to the same root: underqualified providers performing medical procedures in settings without appropriate oversight.
This article is not a directory. It does not rank providers. It explains what credentials mean, what supervision actually requires, what red flags look like in practice, and what questions to ask before letting anyone near your face with a needle.
What the credentials mean
Board-certified dermatologist (MD or DO). Completed a 4-year dermatology residency after medical school, passed the American Board of Dermatology certification exam, and maintains certification through continuing education and re-examination. Dermatologists have the deepest training in skin anatomy, vascular anatomy of the face, and management of complications like vascular occlusion. They can independently prescribe, diagnose, and perform procedures in all 50 states.
Board-certified plastic surgeon (MD or DO). Completed a 5–6 year plastic surgery residency (integrated) or a 3-year plastic surgery fellowship after a general surgery residency. Certified by the American Board of Plastic Surgery. Their training emphasizes facial anatomy, surgical and nonsurgical techniques, and complication management. Like dermatologists, they practice independently in all states.
Facial plastic surgeon (MD or DO). Typically board-certified in otolaryngology (ENT) with a fellowship in facial plastic and reconstructive surgery, certified by the American Board of Facial Plastic and Reconstructive Surgery. Their practice is limited to the face, head, and neck, which means concentrated expertise in facial anatomy.
Nurse practitioner (NP). Completed a master's or doctoral NP program, passed national certification. Scope of practice varies dramatically by state. In "full practice authority" states (approximately 27 plus DC), NPs can evaluate, diagnose, and prescribe independently. In "reduced practice" and "restricted practice" states, they require a collaborative agreement or physician supervision. Even in full-practice states, aesthetic injection is not typically part of NP training — it requires additional, specialized coursework.
Physician assistant (PA). Completed an accredited PA program (master's level), passed the PANCE certification exam. PAs require physician supervision in all states, though the level of supervision (on-site vs. available by phone) varies. The supervising physician does not need to be present in the room for every injection, but must be available for consultation and has legal responsibility for the patient's care.
Registered nurse (RN). Completed an accredited nursing program (associate's or bachelor's degree), passed the NCLEX-RN. RNs almost universally require physician delegation and supervision to perform cosmetic injections. Some states require the supervising physician to be on-site; others allow off-site supervision if written protocols are established. RNs do not have prescriptive authority — a physician or NP must prescribe the medication and establish the treatment plan.
Licensed aesthetician / cosmetologist. Cannot legally inject Botox, dermal fillers, or any prescription medication in any state. They can perform topical treatments, microneedling (without RF, in most states), chemical peels within defined depth limits, and laser treatments where state law permits. Any aesthetician injecting neuromodulators or fillers is operating outside their scope of practice.
Dentist (DDS/DMD). In many states, dentists can administer Botox and fillers within the facial region, as it falls within their scope of oral and maxillofacial expertise. The specific scope varies — some states limit injectables to the perioral area, others extend to the full face. Dentists have strong knowledge of facial and perioral anatomy, but their training in aesthetic injection technique and complication management varies by program.
How supervision actually works (and when it does not)
Supervision is not a binary. It exists on a spectrum, and the label "physician-supervised" on a clinic website does not tell you where on that spectrum the practice falls.
Direct, on-site supervision. The supervising physician is physically present in the clinic, has examined the patient, established the treatment plan, and is available to manage complications immediately. This is the gold standard — and the legal requirement in several states for RN-delivered injections.
Off-site supervision with protocols. The physician has established written treatment protocols, is available by phone or video for consultation, and has examined the patient (sometimes via telemedicine, though the rules on this continue to evolve). The physician may visit the clinic periodically. This is legal in many states but provides less immediate safety coverage than on-site supervision.
Nominal supervision. The physician's name is on the medical director agreement, but they have not examined the patient, have not established individualized treatment protocols, and are not readily available. The physician may be supervising dozens of clinics simultaneously. This arrangement is legal in some states but represents the lowest level of actual oversight. It is also the arrangement most commonly associated with adverse events.
The American Association of Cosmetic Medicine's 2025 regulatory guidance recommends that practices confirm delegation and supervision mechanics in writing — naming the delegating physician, defining screening criteria, outlining complication management, and specifying supervision availability. If a clinic cannot clearly articulate who the supervising physician is, when they are present, and how complications are managed, that is a structural safety gap.
What to look for: the positive signals
The injector tells you what they would not do. A good injector declines treatments that are not appropriate — "I would not recommend filler in this area given your anatomy" or "You do not need Botox in that muscle group yet." Unconditional agreement with every patient request is not patient-centered care; it is avoiding a necessary clinical conversation.
The clinic stocks hyaluronidase on site. Hyaluronidase is the enzyme that dissolves hyaluronic acid filler. It is the emergency treatment for vascular occlusion — a rare but potentially devastating complication where filler blocks a blood vessel, risking skin necrosis or blindness. If a clinic performs HA filler injections and does not have hyaluronidase immediately available, they cannot manage the most time-sensitive complication in aesthetic medicine. This is a hard disqualifier.
The consultation is separate from the treatment. A proper consultation includes assessment of facial anatomy, review of medical history, discussion of risks and benefits, and development of a treatment plan — without the immediate pressure of proceeding to injection. Consultations that immediately become sales pitches for the maximum number of syringes are a warning sign.
The injector asks about your complete treatment history. Previous fillers, neuromodulators, biostimulators, laser treatments, and surgeries all affect treatment planning. An injector who does not ask about prior treatments is flying blind.
Product sourcing is verifiable. Counterfeit Botox and filler are documented safety issues. The FDA and CDC have reported multi-state incidents of hospitalizations tied to counterfeit neurotoxin and injections by unqualified providers. Legitimate clinics purchase product directly from manufacturers or authorized distributors. If a clinic refuses to identify the product by brand name or lot number, or if the pricing suggests product that is far below market cost, the product may be diverted, expired, or counterfeit.
Before-and-after photos are realistic. Clinics that show only dramatic transformations are curating for marketing. Natural, subtle results — the kind most patients actually want — are harder to photograph but more representative of good practice. Clinics that show only dramatic results may be optimizing for social media, not for patient outcomes.
Red flags
No consultation before treatment. Injecting on the first visit, without a prior assessment, means the injector has not evaluated your anatomy, medical history, or suitability for the proposed treatment. This is how complications happen.
Pricing that is dramatically below market rate. The cost of FDA-approved product, appropriate training, and a safe clinical environment is real. Injectors who significantly undercut market rates are cutting something — product quality, training, hygiene, or safety infrastructure.
No hyaluronidase on site. Stated again because it is that important. If a clinic injects HA filler and cannot confirm that hyaluronidase is stocked and immediately accessible, leave.
Heavy reliance on social media before-and-afters. Filters, lighting, and selective posting make social media a poor proxy for clinical quality. A large Instagram following is a marketing metric, not a safety credential.
The injector agrees with everything you suggest. Clinical expertise sometimes means saying no. An injector who never pushes back, never suggests an alternative, and never declines a treatment the patient is requesting is not providing medical oversight — they are processing transactions.
The provider will not state their credentials clearly. If you ask "Are you a board-certified dermatologist or plastic surgeon?" and the answer is evasive, overly complicated, or redirects to their "certification" from a weekend training course, the credential does not support the claim. Board certification is verifiable through the American Board of Medical Specialties (abms.org).
The clinic name obscures the medical oversight. Many med spas use branding that does not identify the supervising physician, the medical director, or the nature of the medical license under which procedures are performed. Transparency about medical oversight is a baseline expectation. Opaque branding is not necessarily a red flag on its own — but combined with other warning signs, it suggests a practice that prioritizes aesthetics over accountability.
Training courses are not board certification
The distinction matters. A "certified aesthetic injector" who completed a weekend training course is not equivalent to a board-certified dermatologist with 4 years of residency and a board exam. Both may be capable of performing routine injections without complications. But when something goes wrong — vascular occlusion, anaphylaxis, unexpected anatomy — the depth of training predicts the quality of the response.
Training courses from organizations like the American Academy of Facial Esthetics, AAOPM, and AAAMS teach technique, anatomy, and safety fundamentals. They are valuable. They are not board certification. They do not grant prescribing authority. They do not change a provider's legal scope of practice. And the certificate on the wall of a med spa does not mean the provider has the same clinical depth as a physician who trained for years in facial anatomy and complication management.
The PSNCB (Plastic Surgical Nursing Certification Board) offers the Certified Aesthetic Nurse Specialist (CANS) credential, which requires 2+ years of experience with a board-certified physician in plastic surgery, dermatology, or facial plastic surgery, plus a certification exam and recertification every 3 years. This is one of the more rigorous non-physician credentials in the field.
Counterfeit product: an ongoing safety issue
The FDA and CDC have documented multiple incidents of counterfeit botulinum toxin (Botox) causing hospitalizations. These cases involved product sourced outside authorized supply chains and, in some instances, administered by unqualified providers.
Legitimate Botox (onabotulinumtoxinA) is manufactured by Allergan/AbbVie and distributed through controlled supply chains. Legitimate Dysport (abobotulinumtoxinA), Xeomin (incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA-xvfs), and Daxxify (daxibotulinumtoxinA-lanm) each have single manufacturers and authorized distribution channels.
Questions worth asking:
- Can you tell me the brand name and lot number of the product you will use?
- Do you purchase directly from the manufacturer or an authorized distributor?
- Is the product FDA-approved? (Note: FDA-approved and FDA-cleared are different. Injectable drugs like Botox are approved through the NDA/BLA pathway. Devices are cleared through the 510(k) pathway.)
Questions to ask at your consultation
- What is your medical credential (MD, DO, NP, PA, RN, DDS)?
- Are you board-certified? In what specialty?
- Who is the supervising physician for this practice, and are they on-site during treatments?
- Do you have hyaluronidase on site and a protocol for managing vascular occlusion?
- How do you source your products?
- What is your approach when a patient requests something you would not recommend?
- How many patients with my anatomy and concerns have you treated?
- What complications have you managed, and how were they resolved?
- Will my consultation be separate from the treatment session?
- Can I see before-and-after photos of patients with similar anatomy and goals — including results that show subtle, natural improvement?
Sources
- Botox Certification by State: A Complete Regulatory Guide (2026). IAPAM. https://iapam.com/botox-library/botox-certification-by-state
- New Aesthetic Injector Regulations You Need to Know (2025 Update). AACM. https://www.cosmeticinjectors.org/blog/new-aesthetic-injector-regulations-you-need-to-know-2025-update/
- State Regulations for Nurse Practitioners Offering Aesthetic Services. AACM. https://www.cosmeticinjectors.org/blog/state-regulations-for-nurse-practitioners-offering-aesthetic-services/
- How to Choose an Injector. Skin Trek. https://skin-trek.com/nerd/how-to-choose-an-injector
- State-by-State Injection Requirements. AAOPM. https://aaopm.com/admissions/state-requirements/
- New Jersey Med Spa Laws: Key Regulations to Know in 2026. MedSpire Health. https://medspire-health.com/blog/new-jersey-med-spa-laws-key-regulations-to-know-in-2026/
- Botox Laws by State 2026. World Population Review. https://worldpopulationreview.com/state-rankings/botox-laws-by-state
- Aesthetic Practice Advisory Decision. Nevada State Board of Nursing. January 17, 2025. https://nevadanursingboard.org/wp-content/uploads/2025/01/Aesthetic-Practice-Decision-PDF.pdf
- FDA Safety Communication: Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling. October 15, 2025. https://www.fda.gov/medical-devices/safety-communications/potential-risks-certain-uses-radiofrequency-rf-microneedling-fda-safety-communication
- Counterfeit Botox: FDA and CDC multi-state alerts. 2024–2025. https://www.fda.gov/drugs/drug-safety-and-availability/fda-investigating-counterfeit-version-botox-found-united-states
